Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Pitt et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69aed52125c44a431252fd5b — DOI: https://doi.org/10.1056/nejmoa030207

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Prediction of Creatinine Clearance from Serum Creatinine· 2008 · 15,383 citations
2. Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease· 1995 · 316 citations
3. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial· 2001 · 1,817 citations
4. Mechanisms Determining Course and Outcome of Diabetic Patients Who Have Had Acute Myocardial Infarction· 1997 · 305 citations
5. Efficacy and safety of eplerenone, enalapril, and eplerenone/enalapril combination therapy in patients with left ventricular hypertrophy· 2002 · 28 citations